Obstetrics/Gynecology
RSSArticles
-
Research Focuses on Medroxyprogesterone Acetate in Cervical Cancer Prevention
Preliminary research suggests that medroxyprogesterone acetate, the active ingredient in the contraceptive injection DMPA, may be effective in preventing cervical cancer.
-
Policy Update Advocates Teen Access to Emergency Contraception
To help prevent unplanned pregnancy among adolescents, the American Academy of Pediatrics has issued an updated policy statement on emergency contraception (EC) to educate providers on use of EC in adolescents, and advocate for expanded access for teens.
-
Investigational Contraceptive Patch Clears FDA Panel Vote
Twirla, an investigational combined hormonal contraceptive patch, is under review by the FDA. In an October 2019 meeting, the patch received a 14 to 1 vote from the FDA’s Bone, Reproductive, and Urologic Drugs Advisory Committee.
-
FDA Approves Liletta IUD for Six Years of Effective Use
The FDA has approved the Liletta levonorgestrel intrauterine device (IUD) for six years of effective use. The 52 mg device, similar in size to the Mirena IUD, was approved for the U.S. in February 2015.
-
The Time for Contraceptive Revolution Is Now
While the 20th century yielded new contraceptives in the form of pills, rings, patches, intrauterine devices, and implants, it is time for new exploration into further birth control options.
-
The Affordable Care Act: Progress in Reducing the Rate of Unintended Pregnancy
Data from the latest release of the National Survey of Family Growth supports that the contraception coverage mandate of the Affordable Care Act has resulted in a decrease in the incidence of unintended pregnancy, particularly among women with government coverage.
-
PARP Inhibitors: An Adjunct to Initial Standard Treatment for Advanced Ovarian Cancer Patients
The PRIMA study is a randomized, double-blind, multi-institutional, international phase 3 trial testing the PARP inhibitor niraparib against placebo after first-line standard treatment with platinum-based chemotherapy for newly diagnosed ovarian cancer.
-
Influenza and Pertussis Vaccines for Pregnant Women: Are We Doing Enough to Encourage Vaccination?
In this cross-sectional analysis, pregnant women disproportionately accounted for 24-34% of influenza-associated hospitalizations among women aged 15 to 44 years, and infants younger than 2 months of age comprised the highest proportion of pertussis deaths. The reasons why pregnant women did not elect recommended immunizations included not believing they were effective, not knowing they should receive Tdap every pregnancy, and being concerned that the vaccines would harm the fetus.
-
News From the WHI: Soft Drink Consumption and Bone Health
Participants from the Women’s Health Initiative study who reported consumption of more than two soft drinks per day showed a higher incidence of hip fracture compared to those consuming no soft drinks.
-
More Women Look to Self-Managed Medication Abortion
Results of a recent study indicated that online abortion medication demand is highest in states with restrictive abortion policies. Findings showed that from Oct.15, 2017, to Aug. 15, 2018, 6,022 people living in the United States requested abortion medications from an online service. While requests came from across the nation, states with restrictive abortion policies saw higher volumes of requests.